glp-1 weight loss drug news today Serena Williams Is the Surprising New Face of Weight-Loss Drugs The FDA approved a new
Description
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same
Ethics declarations Ethical approval and consent to participate Not applicable
This might relate to GIPs potential effects on food reward pathways or metabolic signaling
doi: 10.1111/jnc.12469 [DOI] [PubMed] [Google Scholar] 197
153 MeierJJKemmeriesGHolstJJNauckMA
